Get the Stockscreener App
4.07
2.26%
0.09
Pre-market:
4.08
0.010
+0.25%
Autonomix Medical Inc stock is traded at $4.07, with a volume of 46,968.
It is up +2.26% in the last 24 hours and down -24.21% over the past month.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
See More
Previous Close:
$3.98
Open:
$4.05
24h Volume:
46,968
Relative Volume:
0.01
Market Cap:
$7.98M
Revenue:
-
Net Income/Loss:
$-16.72M
P/E Ratio:
-0.0636
EPS:
-64.0349
Net Cash Flow:
$-12.29M
1W Performance:
-4.91%
1M Performance:
-24.21%
6M Performance:
-55.26%
1Y Performance:
-81.72%
1-Day Range:
$3.94
$4.18
1-Week Range:
$3.90
$4.39
52-Week Range:
$2.44
$32.55
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical Inc
Sector
Industry
Phone
832-277-7816
Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
4.07 | 7.98M | 0 | -16.72M | -12.29M | -64.03 |
ABT
Abbott Laboratories
|
101.07 | 174.89B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.51 | 113.22B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
269.75 | 103.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.68 | 64.75B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 49.41B | 6.30B | 1.07B | 1.09B | 1.8406 |
Autonomix Medical Inc Stock (AMIX) Latest News
Autonomix Medical receives European patent for neural assessment technology By Investing.com - Investing.com Canada
Autonomix Medical receives European patent for neural assessment technology - Investing.com
Autonomix Medical Expands Global Intellectual Property - GlobeNewswire
Autonomix Medical (NASDAQ: AMIX) Welcomes Sandra Kalter to Board of Directors - Kalkine Media
Autonomix Medical appoints Sandra Cohen Kalter to board - Medical Buyer
Autonomix Medical appoints Sandra Cohen Kalter to board By Investing.com - Investing.com South Africa
Autonomix Medical Adds Former Medtronic Regulatory Executive Sandra Kalter to Board - citybiz
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors - The Manila Times
Sandra Kalter appointed to Autonomix Medical board as independent director - TradingView
Autonomix Medical, Inc. SEC Filing (Sep 16, 2026) - Stock Titan
Another reverse split vote ahead for Autonomix (NASDAQ: AMIX) - Stock Titan
Autonomix Medical stock halts, surges 116% on preclinical data - scanx.trade
Reverse split vote looms for Autonomix Medical (AMIX) - stocktitan.net
AMIX Stock Quote Price and Forecast - CNN
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026 - The Manila Times
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery - The Manila Times
Autonomix Medical Shares More Than Double After Hours on $4.9 Million Warrant Exercise Deal - finance.biggo.com
Autonomix Medical enters into warrant inducement agreement - Medical Buyer
Autonomix Medical Shares Surge Pre-Bell After $4.9 Million Warrant Inducement Priced at Premium to Market - marketscreener.com
Trending Stocks Today | Autonomix Medical Soars 138.64% Post-Market - Moomoo
Autonomix (AMIX) Range: Closes 1.90% Higher at $5.37 in the Latest Session - vinanet.vn
Autonomix (AMIX) Levels: Records a Muted Move to $5.27 in the Latest Reading; Trading Range - vinanet.vn
Autonomix Medical secures U.S. patent for precision nerve sensing and cancer pain therapy - scanx.trade
Autonomix (AMIX) Momentum: Moves 10.83% Down to $5.27 in the Latest Reading; Trading Range: $5.01 and $5.53 Define the Nearby Reference Levels in the Current UpdateVolume Gap - vinanet.vn
Autonomix Medical enters $2.6 million warrant inducement agreement - scanx.trade
Autonomix (AMIX) Earnings Reading: Profit Per Share Surpasses Its Benchmark at the Close; Share Response: The Stock Records a 4.21% Decrease in Latest TradingEPS Surprise History - vinanet.vn
Autonomix (AMIX) Quarterly Results: EPS Prints Above Forecast; After Earnings: Shares Fall 3.40% in the Current UpdateReturn On Assets - dars.gov.et
Autonomix (AMIX) Quarterly Update: EPS Lands Above Forecast in the Current Update; Price Reaction: Shares Finish 5.86% Down in the Latest SessionFinancial Health Score - dars.gov.et
Autonomix Medical completes pre-clinical study for FDA submission By Investing.com - Investing.com Nigeria
Autonomix Medical (AMIX) Holds at $6.85 as Narrow Trading Range Defines Near-Term OutlookETF Creation Redemption - vinanet.vn
Price to sales forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Autonomix Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
Autonomix Medical Q1 Results: EPS of $(5.02) beats estimate - scanx.trade
Autonomix Medical (AMIX) flags going-concern risk and $25–$30M funding need - Stock Titan
Autonomix Medical, Inc. (AMIX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Autonomix Medical Stock Short Interest Rises to 50.21% - Moomoo
Autonomix Medical completes pre-clinical study for FDA submission - Investing.com
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission - The Manila Times
Autonomix Medical Completes GLP Pre-Clinical Study, Advancing FDA Submission - Quiver Quantitative
Autonomix CMO Robert Schwartz receives lifetime award - Investing.com
Autonomix CMO Robert Schwartz receives cardiovascular award By Investing.com - Investing.com Australia
Autonomix CMO Robert Schwartz receives lifetime award By Investing.com - Investing.com South Africa
Autonomix CMO Robert Schwartz receives cardiovascular award - Investing.com
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award - The Manila Times
Autonomix Medical Inc Stock (AMIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):